Evidence map›Paper›PMID 33319412›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2021

Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network.

Kazuomi Kario, Satoshi Hoshide, Yook-Chin Chia, Peera Buranakitjaroen, Saulat Siddique, Jinho Shin, Yuda Turana, Sungha Park, Kelvin Tsoi, Chen-Huan Chen and 16 more

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Accuracy of a wearable watch-type oscillometric blood pressure monitor in rest and ambulatory blood pressure measurements.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Correlations of the Circadian Rhythmicity of Blood Pressure With Erectile Dysfunction.Journal of clinical hypertension (Greenwich, Conn.) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 14 countries.

Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0001-7541-5751
Yook-Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.ORCID 0000-0003-1995-0359
Peera BuranakitjaroenDivision of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-4710-2413
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.ORCID 0000-0003-1294-0430
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.ORCID 0000-0001-6706-6504
Yuda TuranaSchool of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.ORCID 0000-0003-4527-0285
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.ORCID 0000-0001-5362-478X
Kelvin TsoiJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong.ORCID 0000-0001-5580-7686
Chen-Huan ChenInstitute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.ORCID 0000-0002-9262-0287
Hao-Min ChengInstitute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan.ORCID 0000-0002-3885-6600
Takeshi FujiwaraDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0003-4151-2806
Yan LiCentre for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Van Minh HuynhDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Vietnam.ORCID 0000-0003-4273-4187
Michiaki NagaiDepartment of Internal Medicine, General Medicine and Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan.ORCID 0000-0002-3838-1369
Jennifer NailesDepartment of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Jorge SisonSection of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines.
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Guru Prasad SogunuruMIOT International Hospital, Chennai, India.ORCID 0000-0002-1410-9328
Apichard SukonthasarnCardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand.
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.ORCID 0000-0001-7657-4383
Boon Wee TeoDivision of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore.ORCID 0000-0002-4911-8507
Narsingh VermaDepartment of Physiology, King George's Medical University, Lucknow, India.ORCID 0000-0003-0348-7419
Tzung-Dau WangCardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.ORCID 0000-0002-7180-3607
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0001-8142-8305
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Jichi Medical University · JPNational Yang Ming Chiao Tung University · TWRuijin Hospital · CNAtma Jaya Catholic University of Indonesia · IDChiang Mai University · THChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese University of Hong Kong · HKHanyang University Medical Center · KRHiroshima General Hospital · JPHue University · VNKing George's Medical University · INMadras Institute of Orthopaedics and Traumatology · INNational Taiwan University Hospital · TWPelita Harapan University · IDPunjab Medical Center · PKSiriraj Hospital · THTan Tock Seng Hospital · SGUniversity of Malaya · MYUniversity of the East Ramon Magsaysay Memorial Medical Center · PHYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is an important public health issue due to its association with a number of serious diseases, including cardiovascular disease and stroke. The importance of evaluating hypertension taking into account different blood pressure (BP) profiles and BP variability (BPV) is increasingly being recognized, and is particularly relevant in Asian populations given the specific features of hypertension in the region (including greater salt sensitivity and a high rate of nocturnal hypertension). Ambulatory BP monitoring (ABPM) is the gold standard for diagnosing hypertension and assessing 24-hour BP and provides data on several important parameters that cannot be obtained using any other form of BP measurement. In addition, ABPM parameters provide better information on cardio- and cerebrovascular risk than office BP. ABPM should be used in all patients with elevated BP, particularly those with unstable office or home BP, or who are suspected to have white-coat or masked hypertension. ABPM is also an important part of hypertension diagnosis and monitoring in high-risk patients. ABPM needs to be performed using a validated device and good practice techniques, and has a role both in hypertension diagnosis and in monitoring the response to antihypertensive therapy to ensure strict BP control throughout the 24-hour period. Use of ABPM in clinical practice may be limited by cost and accessibility, and practical education of physicians and patients is essential. The ABPM evidence and practice points in this document are based on the Hypertension Cardiovascular Outcome Prevention and Evidence (HOPE) Asia Network expert panel consensus recommendations for ABPM in Asia.

Indexed as

Blood Pressure Monitoring, AmbulatoryHypertensionAntihypertensive AgentsAsiaBlood PressureBlood Pressure DeterminationHumansAntihypertensive Agentsambulatory blood pressure monitoringblood pressure controlclinical practiceguidelineshypertension

Identifiers

PMID33319412
PMCPMC8029567
OpenAlexW3111663266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.